MERCK KGAA O.N. | 147.30 / +0.44% |
Date/Time | 04/13 / 19:30 |
Chg. / Chg.(%) | 0.65 / +0.44% |
Bid | - |
Ask | - |
Open | 147.00 |
Previous Close | 146.65 |
High | 148.30 |
Low | 145.90 |
Volume [EUR] | 0.00 |
Volume [Units] | 0 |
Price fixings | 21 |
ISIN | DE0006599905 |
Security | MRK |
Exchange | Düsseldorf |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 147.65 | ![]() |
237,910 |
Cboe Europe .. | 147.68 | ![]() |
73,466 |
Turquoise | 147.70 | ![]() |
34,405 |
London Inter.. | 147.65 | ![]() |
10,725 |
TradeGate | 148.450 | ![]() |
8,821 |
Stuttgart | 148.000 | ![]() |
2,430 |
Cboe Europe .. | 147.75 | ![]() |
2,027 |
Cboe Europe .. | 147.68 | ![]() |
909 |
Frankfurt | 147.9000 | ![]() |
287 |
Borsa Italia.. | 147.90 | ![]() |
223 |
gettex | 148.250 | ![]() |
189 |
Hamburg | 147.60 | ![]() |
40 |
Nasdaq Other.. | 175.5060 | ![]() |
14 |
Hannover | 146.00 | ![]() |
12 |
Vienna Globa.. | 147.75 | ![]() |
0 |
Düsseldorf | 147.30 | ![]() |
0 |
München | 146.95 | ![]() |
0 |
Berlin | 146.70 | ![]() |
0 |
Lang & Schwa.. | 147.900 | ![]() |
|
EUREX | Options |
News
- BLU SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.
04/13/2021 / 19:02 - GlobeNewswire - NKMax and Merck KGaA, Darmstadt, Germany Expand Clinical Collaboration to Include Phase I/IIa Trial Investigating the Combination of SNK01 with ERBITUX® (cetuximab) in Metastatic NSCLC
04/13/2021 / 15:30 - GlobeNewswire - Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer
04/08/2021 / 14:00 - GlobeNewswire - PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
04/07/2021 / 22:01 - GlobeNewswire - F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration
04/01/2021 / 14:00 - GlobeNewswire